Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingbin Kong

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|May 11, 2018
[Establishment of a mice model with liver-specific AMP-activated protein kinase gene knockout]Xinghong Tang, Qingbin Kong, Yangfu Jiang, et al.
Frontiers in Oncology|January 8, 2025
Multiple sarcomatoid carcinoma of the small intestine with perforation as the initial symptom: case report and review of the literatureJixin Fu, Qingbin Kong, Xin Sui, et al.
Experimental Hematology & Oncology|September 26, 2018
Mechanisms for estrogen receptor expression in human cancerHui Hua, Hongying Zhang, Qingbin Kong, et al.
Oncology Letters|May 4, 2026
[Retracted] Interleukin-17 promotes the development of cisplatin resistance in colorectal cancerGuolong Sui, Yingna Qiu, Haijuan Yu, et al.
Journal of Hematology & Oncology|June 5, 2020
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapyHui Hua, Qingbin Kong, Jie Yin, et al.
Medicinal Research Reviews|June 2, 2018
Complex roles of the old drug aspirin in cancer chemoprevention and therapyHui Hua, Hongying Zhang, Qingbin Kong, et al.
Oncology Letters|January 19, 2019
Interleukin-17 promotes the development of cisplatin resistance in colorectal cancerGuolong Sui, Yingna Qiu, Haijuan Yu, et al.
Plos One|November 1, 2012
Aflatoxin B1 up-regulates insulin receptor substrate 2 and stimulates hepatoma cell migrationYanli Ma, Qingbin Kong, Hui Hua, et al.
Experimental Hematology & Oncology|December 9, 2020
Complex roles of cAMP-PKA-CREB signaling in cancerHongying Zhang, Qingbin Kong, Jiao Wang, et al.
Journal of Hematology & Oncology|July 7, 2019
Targeting mTOR for cancer therapyHui Hua, Qingbin Kong, Hongying Zhang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|May 11, 2018
[Establishment of a mice model with liver-specific AMP-activated protein kinase gene knockout]Xinghong Tang, Qingbin Kong, Yangfu Jiang, et al.
Frontiers in Oncology|January 8, 2025
Multiple sarcomatoid carcinoma of the small intestine with perforation as the initial symptom: case report and review of the literatureJixin Fu, Qingbin Kong, Xin Sui, et al.
Experimental Hematology & Oncology|September 26, 2018
Mechanisms for estrogen receptor expression in human cancerHui Hua, Hongying Zhang, Qingbin Kong, et al.
Oncology Letters|May 4, 2026
[Retracted] Interleukin-17 promotes the development of cisplatin resistance in colorectal cancerGuolong Sui, Yingna Qiu, Haijuan Yu, et al.
Journal of Hematology & Oncology|June 5, 2020
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapyHui Hua, Qingbin Kong, Jie Yin, et al.
Medicinal Research Reviews|June 2, 2018
Complex roles of the old drug aspirin in cancer chemoprevention and therapyHui Hua, Hongying Zhang, Qingbin Kong, et al.
Oncology Letters|January 19, 2019
Interleukin-17 promotes the development of cisplatin resistance in colorectal cancerGuolong Sui, Yingna Qiu, Haijuan Yu, et al.
Plos One|November 1, 2012
Aflatoxin B1 up-regulates insulin receptor substrate 2 and stimulates hepatoma cell migrationYanli Ma, Qingbin Kong, Hui Hua, et al.
Experimental Hematology & Oncology|December 9, 2020
Complex roles of cAMP-PKA-CREB signaling in cancerHongying Zhang, Qingbin Kong, Jiao Wang, et al.
Journal of Hematology & Oncology|July 7, 2019
Targeting mTOR for cancer therapyHui Hua, Qingbin Kong, Hongying Zhang, et al.
Pageof 2